CN111358867A - Eye drop for treating cataract - Google Patents
Eye drop for treating cataract Download PDFInfo
- Publication number
- CN111358867A CN111358867A CN201811596061.3A CN201811596061A CN111358867A CN 111358867 A CN111358867 A CN 111358867A CN 201811596061 A CN201811596061 A CN 201811596061A CN 111358867 A CN111358867 A CN 111358867A
- Authority
- CN
- China
- Prior art keywords
- eye drop
- gall powder
- powder
- honeysuckle
- pipewort
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003889 eye drop Substances 0.000 title claims abstract description 26
- 208000002177 Cataract Diseases 0.000 title claims abstract description 25
- 239000000843 powder Substances 0.000 claims abstract description 46
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 34
- 241000270295 Serpentes Species 0.000 claims abstract description 21
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 20
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 19
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 19
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 18
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 18
- 241000195955 Equisetum hyemale Species 0.000 claims abstract description 18
- 244000061408 Eugenia caryophyllata Species 0.000 claims abstract description 18
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 18
- 229940116229 borneol Drugs 0.000 claims abstract description 18
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 18
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 18
- 244000112814 pipewort Species 0.000 claims abstract description 18
- 239000011780 sodium chloride Substances 0.000 claims abstract description 17
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 239000000706 filtrate Substances 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 abstract description 11
- 230000004438 eyesight Effects 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 8
- 229940079593 drug Drugs 0.000 abstract description 6
- 230000007547 defect Effects 0.000 abstract description 4
- 239000005304 optical glass Substances 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 230000000007 visual effect Effects 0.000 abstract 1
- 241000475481 Nebula Species 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 240000000572 Blumea balsamifera Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 102000014824 Crystallins Human genes 0.000 description 1
- 108010064003 Crystallins Proteins 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- -1 luteolin glycoside Chemical class 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000030212 nutrition disease Diseases 0.000 description 1
- 208000019180 nutritional disease Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Ophthalmology & Optometry (AREA)
- Nutrition Science (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention provides an eye drop for treating cataract, which comprises the following raw materials in parts by weight: 80-100 g of pipewort, 80-100 g of scouring rush, 60-80 g of honeysuckle, 60-80 g of cassia seed, 5-15 g of bear gall powder, 5-15 g of snake gall powder, 5-15 g of white clove, 5-15 g of borneol and 5-15 g of sodium chloride. The eye drop is used for treating cataract, inherits the traditional Chinese medicine concept, does not need to be operated, shaped, injected or taken, and is safe and stable. The invention overcomes the defects of easy occurrence of side effect and easy recurrence in drug treatment, risk and sequelae in operation treatment, and the problems that only daily visual objects of patients with eyesight defects can be solved but symptoms are not treated only by wearing optical glasses, and the like.
Description
Technical Field
The invention belongs to the field of medicines, and particularly relates to an eye drop for treating cataract.
Technical Field
Cataract is an eye disease in which the lens metabolism is disturbed due to aging, genetic, local nutritional disorder, immune and metabolic disorder, trauma, poisoning, radiation and other reasons, and the lens protein is denatured to generate opacity. At this time, the light is obstructed by the turbid lens and cannot be projected on the retina, resulting in blurred vision. It is commonly over 40 years old and has an increasing incidence with age. The existing cataract eye treatment methods comprise operation treatment and drug treatment, the operation treatment has risks and sequelae, and the drug treatment has certain side effects and is easy to relapse.
Therefore, how to develop a preparation for rapidly treating cataract becomes a practical topic.
Disclosure of Invention
The invention aims to provide the eye drop for treating the cataract, which inherits the traditional Chinese medicine concept and has obvious effect of treating the cataract.
In order to achieve the purpose, the eye drop for treating cataract comprises the following raw materials in parts by weight: 80-100 g of pipewort, 80-100 g of scouring rush, 60-80 g of honeysuckle, 60-80 g of cassia seed, 5-15 g of bear gall powder, 5-15 g of snake gall powder, 5-15 g of white clove, 5-15 g of borneol and 5-15 g of sodium chloride.
Preferably, the feed comprises the following raw materials in parts by weight: 80 g of pipewort, 80 g of scouring rush, 60 g of honeysuckle, 60 g of cassia seed, 5 g of bear gall powder, 5 g of snake gall powder, 5 g of white clove, 5 g of borneol and 5 g of sodium chloride.
Preferably, the feed comprises the following raw materials in parts by weight: 90 g of pipewort, 90 g of scouring rush, 70 g of honeysuckle, 70 g of cassia seed, 10 g of bear gall powder, 10 g of snake gall powder, 10 g of white clove, 10 g of borneol and 10 g of sodium chloride.
Preferably, the feed comprises the following raw materials in parts by weight: 100 g of pipewort, 100 g of scouring rush, 80 g of honeysuckle, 80 g of cassia seed, 15 g of bear gall powder, 15 g of snake gall powder, 15 g of white clove, 15 g of borneol and 15 g of sodium chloride.
Further, the preparation method of the eye drop for treating cataract of the invention comprises the following steps:
1) putting pipewort, scouring rush, honeysuckle and cassia seed slices into a marmite with water, decocting with slow fire for 2-3 hours, filtering and collecting filtrate for later use;
2) grinding flos Caryophylli into fine powder.
3) And (2) adding bear gall powder, snake gall powder and white clove powder into the filtrate obtained in the step (1), adding borneol and sodium chloride, stirring uniformly, adjusting the pH value to 6-7, sterilizing and subpackaging to obtain the eye drop.
The main raw materials are explained below:
pipewort: has the functions of dispelling wind and heat, improving eyesight and removing nebula. Can be used for treating conjunctival congestion due to wind-heat, swelling pain, photophobia, nebula generation, headache due to wind-heat, etc.
Scouring rush: dispel wind-heat and remove nebula. It enters lung, liver and gallbladder meridians, and can clear wind-heat in three meridians, so it is a wind-dispelling, nebula-removing and vision-improving herb.
Honeysuckle flower: the efficacy of the traditional Chinese medicine is mainly to clear away heat and toxic materials and mainly treat epidemic febrile disease fever, heat toxin and bloody dysentery, carbuncle, cellulitis, furuncle and the like. Modern researches prove that the honeysuckle contains pharmacological active ingredients such as chlorogenic acid and luteolin glycoside, has stronger inhibitory power on various pathogenic bacteria such as hemolytic streptococcus, staphylococcus aureus and the like and upper respiratory infection pathogenic viruses and the like, can enhance immunity, resist early pregnancy, protect liver, resist tumor, diminish inflammation, relieve fever, stop bleeding (blood coagulation), inhibit intestinal absorption of cholesterol and the like, has very wide clinical application, and can be used for treating more than 40 diseases such as respiratory infection, bacillary dysentery, acute urinary infection, hypertension and the like by being compatible with other medicines. The honeysuckle flower soaked or decocted for frequent taking is beneficial to the treatment and rehabilitation of wind-fire red eyes, sore throat, obesity, liver heat and liver heat type hypertension.
Cassia seed: cassia seed, bitter, sweet, salty and slightly cold in nature, enters liver, kidney and large intestine meridians; loosening bowel to relieve constipation, reducing blood lipid, improving eyesight, and treating constipation, hyperlipemia, and hypertension.
Bear gall powder: clear heat, pacify liver, improve vision. It can be used for treating conjunctival congestion, swelling and pain of throat.
The snake gall powder: the snake gall is the gall bladder storing bile in the snake body. The snake gall is cool in nature and bitter and slightly sweet in taste; has effects in expelling pathogenic wind, removing dampness, refreshing mind, improving eyesight, removing toxic materials, and removing miliaria; can be used for regulating and nourishing nervous system, endocrine system and immune system, and delaying aging.
Pearl: has the effects of tranquilizing, arresting convulsion, improving eyesight, removing nebula, removing toxic substance, and promoting granulation. Can be used for treating palpitation, insomnia, infantile convulsion, epilepsy, nebula, eye cloudiness, and unhealing sore and ulcer.
White clove: has the effects of removing food retention and improving eyesight. It is used for treating hernia and accumulation. It is used externally to treat nebula, carbuncle, deep-rooted carbuncle, sore, furuncle and tonsillitis.
Borneol: is prepared from stems and leaves of blumea balsamifera of Compositae or branches and leaves of Cinnamomum camphora of Lauraceae by steam distillation and recrystallization, or from oleum Terebinthinae by a series of chemical processes. It can be used for treating block pattern of coma, conjunctival congestion with swelling and pain, pharyngitis, aphtha, sore and ulcer with swelling and pain, and unhealed ulcer.
The substantive characteristics and the remarkable progress of the invention are as follows:
the eye drop is used for treating cataract; inherits the traditional Chinese medicine concept, does not need to be operated, shaped, injected or taken, and is safe and stable. The invention overcomes the defects of easy occurrence of side effect and easy recurrence in drug treatment, risk and sequelae in operation treatment, and the problems that only daily vision objects of patients with eyesight defects can be solved but symptoms are not treated only by wearing optical glasses, and the like.
Detailed Description
The technical scheme of the invention is further illustrated by the following specific examples.
Example 1
The eye drop for treating cataract comprises the following raw materials in parts by weight: 80 g of pipewort, 80 g of scouring rush, 60 g of honeysuckle, 60 g of cassia seed, 5 g of bear gall powder, 5 g of snake gall powder, 5 g of white clove, 5 g of borneol and 5 g of sodium chloride. The preparation method of the eye drop for treating cataract comprises the following steps:
1) putting pipewort, scouring rush, honeysuckle and cassia seed slices into a marmite with water, decocting with slow fire for 2-3 hours, filtering and collecting filtrate for later use;
2) grinding flos Caryophylli into fine powder.
3) And (2) adding bear gall powder, snake gall powder and white clove powder into the filtrate obtained in the step (1), adding borneol and sodium chloride, stirring uniformly, adjusting the pH value to 6-7, sterilizing and subpackaging to obtain the eye drop.
Example 2
The eye drop for treating cataract comprises the following raw materials in parts by weight: 90 g of pipewort, 90 g of scouring rush, 70 g of honeysuckle, 70 g of cassia seed, 10 g of bear gall powder, 10 g of snake gall powder, 10 g of white clove, 10 g of borneol and 10 g of sodium chloride.
The preparation method of the eye drop for treating cataract comprises the following steps:
1) putting pipewort, scouring rush, honeysuckle and cassia seed slices into a marmite with water, decocting with slow fire for 2-3 hours, filtering and collecting filtrate for later use;
2) grinding flos Caryophylli into fine powder.
3) And (2) adding bear gall powder, snake gall powder and white clove powder into the filtrate obtained in the step (1), adding borneol and sodium chloride, stirring uniformly, adjusting the pH value to 6-7, sterilizing and subpackaging to obtain the eye drop.
Example 3
The eye drop for treating cataract comprises the following raw materials in parts by weight: 100 g of pipewort, 100 g of scouring rush, 80 g of honeysuckle, 80 g of cassia seed, 15 g of bear gall powder, 15 g of snake gall powder, 15 g of white clove, 15 g of borneol and 15 g of sodium chloride.
The preparation method of the eye drop for treating cataract comprises the following steps:
1) putting pipewort, scouring rush, honeysuckle and cassia seed slices into a marmite with water, decocting with slow fire for 2-3 hours, filtering and collecting filtrate for later use;
2) grinding flos Caryophylli into fine powder.
3) And (2) adding bear gall powder, snake gall powder and white clove powder into the filtrate obtained in the step (1), adding borneol and sodium chloride, stirring uniformly, adjusting the pH value to 6-7, sterilizing and subpackaging to obtain the eye drop.
The eye drop of the invention inherits the traditional Chinese medicine concept, has obvious effect on treating cataract, and is safe and effective.
Claims (5)
1. An eye drop for treating cataract is characterized by comprising the following raw materials in parts by weight: 80-100 g of pipewort, 80-100 g of scouring rush, 60-80 g of honeysuckle, 60-80 g of cassia seed, 5-15 g of bear gall powder, 5-15 g of snake gall powder, 5-15 g of white clove, 5-15 g of borneol and 5-15 g of sodium chloride.
2. The eye drop for treating cataract as claimed in claim 1, wherein: the feed comprises the following raw materials in parts by weight: 80 g of pipewort, 80 g of scouring rush, 60 g of honeysuckle, 60 g of cassia seed, 5 g of bear gall powder, 5 g of snake gall powder, 5 g of white clove, 5 g of borneol and 5 g of sodium chloride.
3. The eye drop for treating cataract as claimed in claim 1, wherein: the feed comprises the following raw materials in parts by weight: 90 g of pipewort, 90 g of scouring rush, 70 g of honeysuckle, 70 g of cassia seed, 10 g of bear gall powder, 10 g of snake gall powder, 10 g of white clove, 10 g of borneol and 10 g of sodium chloride.
4. The eye drop for treating cataract as claimed in claim 1, wherein: the feed comprises the following raw materials in parts by weight: 100 g of pipewort, 100 g of scouring rush, 80 g of honeysuckle, 80 g of cassia seed, 15 g of bear gall powder, 15 g of snake gall powder, 15 g of white clove, 15 g of borneol and 15 g of sodium chloride.
5. The method for preparing an eye drop for treating cataract as claimed in claim 1, wherein the steps are as follows:
1) putting pipewort, scouring rush, honeysuckle and cassia seed slices into a marmite with water, decocting with slow fire for 2-3 hours, filtering and collecting filtrate for later use;
2) grinding flos Caryophylli into fine powder.
3) And (2) adding bear gall powder, snake gall powder and white clove powder into the filtrate obtained in the step (1), adding borneol and sodium chloride, stirring uniformly, adjusting the pH value to 6-7, sterilizing and subpackaging to obtain the eye drop.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811596061.3A CN111358867A (en) | 2018-12-24 | 2018-12-24 | Eye drop for treating cataract |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811596061.3A CN111358867A (en) | 2018-12-24 | 2018-12-24 | Eye drop for treating cataract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111358867A true CN111358867A (en) | 2020-07-03 |
Family
ID=71198147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811596061.3A Pending CN111358867A (en) | 2018-12-24 | 2018-12-24 | Eye drop for treating cataract |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111358867A (en) |
-
2018
- 2018-12-24 CN CN201811596061.3A patent/CN111358867A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101279027B (en) | Chinese medicine lotion preparation for curing acute conjunctivitis | |
| CN102631558B (en) | Medicament for treating eye disease and preparation method of medicament | |
| CN104857312A (en) | Traditional Chinese medicine composition for preventing and controlling wound infection and promoting wound repair | |
| KR101118046B1 (en) | An oriental drink comprising a typha orientalis, a sasa borealis, a reed and a zizania caudiflora | |
| CN1900255A (en) | Male body building long life liquor | |
| CN104026676A (en) | Plantain herb soup with function of clearing away heat and toxic materials and production method thereof | |
| CN110787211A (en) | Ginseng eye lotion and preparation method thereof | |
| CN103520649B (en) | The Chinese medicine for the treatment of facial neuritis | |
| CN105125630A (en) | Eye drops and preparation method thereof | |
| CN111358867A (en) | Eye drop for treating cataract | |
| CN102198227B (en) | Method for preparing Chinese medicine for treating yin-deficiency glaucoma | |
| CN104026666A (en) | Plantain herb soup with function of clearing liver for improving eyesight and production method thereof | |
| CN105194443A (en) | Traditional Chinese medicine composition for treating infantile eczema and preparation method of composition | |
| CN103505562B (en) | For treating the Chinese medicine of keratitis | |
| CN101869631B (en) | Toxicant elimination medicament for eyes | |
| CN105943718B (en) | Agilawood compound traditional Chinese medicine composition as well as preparation method and application thereof | |
| CN104523981A (en) | Traditional Chinese medicine preparation for treating optic neuritis and preparation method | |
| CN104983972A (en) | Hordeolum treatment drop and preparation method thereof | |
| CN104623304A (en) | Lotion for treating chronic skin ulcer caused by damp-heat and toxicity accumulation and preparation method of lotion | |
| CN108785365A (en) | A kind of eyedrops for treating myopia | |
| CN103966061B (en) | A kind of blueberry wine promoting blood circulation and removing blood stasis and production method | |
| CN104587364A (en) | Traditional Chinese medicine composition used for treating uveitis | |
| CN106491730A (en) | A kind of treat Chinese medicine composition of glaucoma and preparation method thereof | |
| CN105726984A (en) | Traditional Chinese medicine eye drops for treating eye inflammation and preparation method thereof | |
| CN105770229A (en) | Medicament for treating cataract and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| DD01 | Delivery of document by public notice | ||
| DD01 | Delivery of document by public notice |
Addressee: Xie Bin Document name: Deemed withdrawal notice |